Moreover, TDI-MPI predicted cardiovascular adverse events with reliability similar to that of the E/e’ ratio and NT-ProBNP level; however, they did not determine the accuracy of TDI-MPI in patients with type-I DD without heart failure. The gene discussed is NPPB; the disease is heart failure.